Use of immunomodulatory drugs in patients with eye disorders, Granma 2017-2020
Keywords:
EYE DISEASES, KERATITIS, UVEITIS, IMMUNOLOGIC FACTORS, GAMMA-GLOBULINSAbstract
Background: the torpid progress of chronic eye disorders, with conventional treatments, impels the alternative use of immunomodulators.
Objective: to describe the use of immunomodulators in patients with chronic eye disorders that do not improve with conventional treatments, attended to at the department of immunoallergy of the Clinic of Medical Specialties of Granma, from 2017 through 2020.
Methods: a descriptive study was carried out at the aforementioned clinic and during the period herein declared. Out of a universe of 101 patients, older than 18 years, 96 were chosen by intentional sampling who consented to be treated with immunomodulators, from January 2017 through December 2018, with follow-ups of at least two-year duration. The effectiveness of immunomodulators on keratitis and uveitis was studied. The following drugs were used: Hebertrans, human gamma globulins at 10 % and the combination of this with levamisole or Hebertrans.
Results: treatments were effective in 89,58 % of overall cases, reaching 92,86 % in posterior uveitis. Ten patients could not be controlled, half of them with herpetic keratitis. 61,46 % were treated with Hebertrans, which was effective in 89,83 %. 87,46 % of the patients with herpetic keratitis were controlled with Hebertrans and 90,91 % of the patients suffering from uveitis with human gamma globulins.
Conclusions: the use of immunomodulators in patients with chronic eye disorders was described. Hebertrans, single gamma globulin or its combinations were effective.
Downloads
References
Azher TN, Yin X, Tajfirouz D, Huang AJW, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Cli. Ophthalmol. [revista en internet]. 2017 [citado 15 de febrero de 2021]; 11(25). Disponible en: https://dx.doi.org/10.2147%2FOPTH.S80475.
Ariocha Cambas AA, Parapar Tena SI, González Ramos O, Guerra Almaguer M, de Prada Sánchez C, Lora Domínguez K. Suero autólogo al 50 % en las queratitis bacterianas. Rev Cubana Oftalmol [revista en internet]. 2014 [citado 15 de febrero de 2021]; 27(1): 70-78. Disponible en: http://revoftalmologia.sld.cu/index.php/oftalmologia/article/view/166.
Rivero Reyes RL, Caro Machado Vicente R, Martínez Rotella AD, Pauste Ruíz H, Rodríguez Domínguez L. Igegam: Efecto en el tratamiento de la uveítis anterior aguda. Rev. Cubana Farm. [revista en internet]. 1998 [citado 18 de febrero 2021]; 32(3): 179-187. Disponible en: http://interfazbusqueda.sld.cu/resource/es/cumed-17771.
Abbas AK, Lichtman AH, Pillai S. Inmunología Celular y Molecular 9na ed. Philadelphia: Elsevier; 2018.
Owen Judith A, Punt J, Stranford Sharon A. Kuby. Inmunología. 8va edición. New York: W.H Fredman and Company; 2019.
Miqueli Rodríguez M, López Hernández SM, Ambou Frutos Il. La uveítis y el glaucoma, un reto para el oftalmólogo. Rev. Cubana Oftalmol. [revista en internet]. 2018 [citado 18 de febrero 2021]; 31(3): 1-9. Disponible en: http://revoftalmologia.sld.cu/index.php/oftalmologia/article/view/600.
Rosenbaum J. Uveitis: Etiology, clinical manifestations, and diagnosis. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc [revista en internet]. 2018 [citado 18 de febrero 2021]; 2018. Disponible en: https://www.uptodate.com/contents/uveitis-etiology-clinical-manifestations-and-diagnosis.
Castillo Pérez A C, Martínez Noriega JL, Benítez Merino M del C, López Hernández S, Casas Arias X, Mejía Cruz N. Afectación ocular en la enfermedad injerto contra huésped. Rev. Cubana Oftalmol. [revista en internet] 2020; [citado 15 de febrero de 2021]; 33(1). Disponible en: http://www.revoftalmologia.sld.cu/index.php/oftalmologia/article/view/834.
Mokey Castellanos MO, Álvarez Rivero MB. Queratoplastia penetrante con y sin terapia antiviral en la queratopatía herpética. Rev. Cubana Oftalmol. [revista en internet]. 2020, Mar [citado 18 de febrero 2021]; 33(1). Disponible en: http://www.revoftalmologia.sld.cu/index.php/oftalmologia/article/view/837.
García Milián AJ, Santos Muñoz L, Ciria Martín A. Inmunología y consumo de medicamentos: reacciones adversas de baja frecuencia tipo B. Rev. Medica Electronica [revista en internet]. 2018 [citado 14 de junio 2021]; 40(2). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/2052.
María C, Ibis D, editors. Formulario Nacional de Medicamentos [en línea]. Cuba: Ministerio de Salud Pública; 2018 [citado 26 de abril 2021]. Disponible en: https://instituciones.sld.cu/hospmiguelenriquez/files/2018/01/Formulario-nacional-de-medicamentos.pdf.
Salas Riczer A. Immunomoduladores: usos clínicos y perfil farmacodinamico de los inmunoestimulantes biológicos. Rev Fac Cien Med. [revista en internet]. 2001 [citado 18 de febrero 2021]; 26(2-3): 4-11. Disponible en: https://revistadigital.uce.edu.ec/index.php/CIENCIAS_MEDICAS/article/view/922.
Cruz Barrios MA, Furones Mourelle JA. Beneficio-riesgo del uso de factor de transferencia (Hebertrans®) en la práctica médica habitual. Horiz. sanitario [revista en internet]. 2019, Ago [citado 18 de febrero 2021]; 18(2): 235-242. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7021228.
Pérez Parra Z, Arpasi NL, Padilla CM, Castillo A, Guerra M. Comportamiento Clinicoepidemiológico de los pacientes con diagnóstico de úlcera grave de la córnea. Rev. Cubana Oftalmo. [revista en internet]. 2016 [citado 19 de febrero 2021]; 29(2): 260-270. Disponible en: http://revoftalmologia.sld.cu/index.php/oftalmologia/article/view/446.
Reich M, Ruppenstein M, Becker MD, Mackensen F. Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis. Retina [revista en internet]. 2015 [citado 19 de febrero 2021]; 35(4): 809–819. Disponible en: https://doi.org/10.1097/iae.0000000000000361.
Badawi AE, Moemen D, El-tantawy NL. Epidemiological, clinical and laboratory findings of infectious keratitis at Mansoura Ophthalmic Center, Egypt. Int. J. Ophthalmo.l [revista en internet]. 2017 [citado 19 de febrero 2021]; 10(1): 1–7. Disponible en: https://doi.org/10.18240/ijo.2017.01.10.
Pabón Páramo CA, Noboa Jiménez AM, Orias Durán JM. Enfermedad de Vogt-Koyanagi-Harada. Rev. Méd. Sinerg. [revista en internet]. 2020 [citado 19 de febrero de 2021]; 5(1): e338. Disponible en: https://doi.org/10.31434/rms.v5i1.338.
Hettinga YM, de Groot-Mijnes JD, Rothova A, de Boer JH. Infectious involvement in a tertiary center pediatric uveitis cohort. Br. J. Ophthalmol. [revista en internet]. 2015 [citado 19 de febrero de 2021]; 99(1): 103–107. Disponible en: http://dx.doi.org/10.1136/bjophthalmol-2014-305367.
Abdulaal M, Antonios R, Barikian A, Jaroudi M, Hamam RN. Etiology and clinical features of ocular inflammatory diseases in a tertiary center in Lebanon. Ocul. Immunol. Inflamm. [revista en internet]. 2015, Agos [citado 19 de febrero de 2021]; 23(4): 271-277. Disponible en: https://doi.org/10.3109/09273948.2014.902077.
Barrios Duarte MC, Nardi Becker G, Gubert Muller G, Tuon FF. Infectious keratitis in southern Brazil: a comparison culture negative and culture positive patients. Rev. Bras. Oftalmol. [revista en internet]. 2020 [citado 19 de febrero de 2021]; 79(1): 46-52. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1092661?src=similardocs.
Moshirfar M. A review of corneal endotheliitis and endotheliopathy: differential diagnosis, evaluation and treatment. Ophthalmol Ther [revista en internet]. 2019 [citado 19 de febrero de 2021]; 8(2): 195–213. Disponible en: https://doi.org/10.1007/s40123019-0169-7.
Al Dhahri H, Al Rubaie K, Hemachandran S, et al. Patterns of uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul. Immunol. Inflamm. [revista en internet]. 2015 [citado 19 de febrero de 2021]; 23(4): 311-319. Disponible en: https://doi.org/10.3109/09273948.2014.939197.
Downloads
Published
How to Cite
Issue
Section
License
This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.
Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.